Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Fluorouracil/Irinotecan/Leucovorin Calcium regimen (IFL)

Known as: IFL, Saltz Regimen, 5FU/Leucovorin/Irinotecan 
A combination of agents containing fluorouracil, irinotecan and leucovorin calcium.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
PURPOSE Colon cancers exhibiting DNA mismatch repair (MMR) defects demonstrate distinct clinical and pathologic features… Expand
Highly Cited
2008
Highly Cited
2008
Protection of large natural forest landscapes is a highly important task to help fulfill different international strategic… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Highly Cited
2006
Highly Cited
2006
PURPOSE Bevacizumab is a monoclonal antibody to vascular endothelial growth factor-A (VEGF). In the pivotal trial in metastatic… Expand
Highly Cited
2005
Highly Cited
2005
PURPOSE Bevacizumab (Avastin; Genentech Inc, South San Francisco, CA), a recombinant, humanized anti-vascular endothelial growth… Expand
Highly Cited
2005
Highly Cited
2005
PURPOSE In a phase III trial, combining bevacizumab (BV)--a recombinant, humanized, monoclonal antibody targeting vascular… Expand
Highly Cited
2005
Highly Cited
2005
BACKGROUND A recent phase III trial showed that the addition of bevacizumab, a monoclonal antibody to vascular endothelial growth… Expand
  • table 1
  • table 3
  • figure 1
  • table 4
  • figure 2
Highly Cited
2004
Highly Cited
2004
BACKGROUND Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, has shown promising preclinical and… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Highly Cited
2004
Highly Cited
2004
PURPOSE Three agents with differing mechanisms of action are available for treatment of advanced colorectal cancer: fluorouracil… Expand
Highly Cited
2003
Highly Cited
2003
PURPOSE In North America, no effective therapy has been available for patients with progressive metastatic colorectal cancer… Expand
Review
2001
Review
2001
PURPOSE To review and assign attribution for the causes of early deaths on two National Cancer Institute-sponsored cooperative… Expand